Long-term course in type 2 idiopathic macular telangiectasia. [electronic resource]
Producer: 20140430Description: 2513-20 p. digitalISSN:- 1435-702X
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Combined Modality Therapy
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Humans
- Intravitreal Injections
- Laser Coagulation
- Lasers, Solid-State -- therapeutic use
- Male
- Middle Aged
- Retinal Telangiectasis -- drug therapy
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.